NKTXHealthcareMicro-Cap

Nkarta, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Nkarta, Inc. (NKTX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are NKTX insiders buying or selling?

Nkarta, Inc. insiders reported 15 open-market buys ($290.0M) and 59 sells ($4.7M) across 74 Form 4 filings — a net buying position of $285.3M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 22, 2026)

Total Form 4 filings
74
SEC EDGAR
Insider filers
20
Insider buys (15)
$290.0M
Insider sells (59)
$4.7M

Insider sentiment

Net buying

Net insider flow of $285.3M in net buying.

Recent NKTX insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 22, 2026Paul J HastingsChief Executive OfficerSale1.8K$2.71$4.8K
Jan 20, 2026Paul J HastingsChief Executive OfficerSale26.0K$2.07$53.9K
Jan 20, 2026Nadir MahmoodPresidentSale5.6K$2.07$11.7K
Jun 20, 2025Paul J HastingsChief Executive OfficerSale1.8K$1.79$3.2K
Jan 17, 2025David ShookChief Medical Officer, Head of Research & DevelopmentSale8.6K$2.20$19.0K
Jan 17, 2025Alyssa LevinChief Financial and Business OfficerSale5.8K$2.20$12.8K
Jan 17, 2025Ralph BrandenbergerChief Technical OfficerSale7.4K$2.20$16.4K
Jan 17, 2025Paul J HastingsChief Executive OfficerSale17.4K$2.20$38.2K
Jan 17, 2025Alicia J. HagerChief Legal OfficerSale9.6K$2.20$21.1K
Jul 18, 2024Alicia J. HagerChief Legal OfficerSale3.4K$8.00$27.2K
Jun 20, 2024James TragerChief Scientific OfficerSale456$5.60$2.6K
Jun 20, 2024Paul J HastingsChief Executive OfficerSale1.8K$5.60$9.9K
Jun 20, 2024David ShookChief Medical OfficerSale456$5.60$2.6K
Jun 20, 2024Alicia J. HagerChief Legal OfficerSale727$5.60$4.1K
Jun 20, 2024Ralph BrandenbergerChief Technical OfficerSale229$5.60$1.3K
Mar 29, 2024Peter KolchinskyDirector, 10% OwnerPurchase3.0M$10.00$30.0M
Mar 28, 2024Simeon GeorgeDirectorPurchase2.0M$10.00$20.0M
Mar 5, 2024Ralph BrandenbergerChief Technical OfficerSale8.4K$12.51$104.7K
Feb 15, 2024James TragerChief Scientific OfficerSale4.1K$12.00$49.7K
Jan 18, 2024David ShookChief Medical OfficerSale3.6K$8.74$31.0K
Jan 18, 2024James TragerChief Scientific OfficerSale4.6K$8.74$39.9K
Jan 18, 2024Ralph BrandenbergerChief Technical OfficerSale2.5K$8.74$22.0K
Jan 18, 2024Paul J HastingsChief Executive OfficerSale9.7K$8.74$84.8K
Jan 18, 2024Alicia J. HagerChief Legal OfficerSale4.6K$8.74$39.8K
Aug 23, 2023David ShookChief Medical OfficerSale1.3K$1.83$2.4K

Showing the 25 most recent of 74 Form 4 filings for Nkarta, Inc..

Most active NKTX insiders

  • Paul J Hastings13 filings
  • Ralph Brandenberger13 filings
  • Nadir Mahmood10 filings
  • James Trager9 filings
  • Alicia J. Hager6 filings

Ask anything about NKTX insider activity

Use Trabud's AI agent to query Nkarta, Inc.'s Form 4 history in plain English — "Show me NKTX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

NKTX insider trading FAQ

Are Nkarta, Inc. insiders buying or selling?

Across 74 SEC Form 4 filings, Nkarta, Inc. (NKTX) insiders reported 15 open-market purchases totaling $290.0M and 59 sales totaling $4.7M. That is a net buying position of $285.3M.

How many insiders trade NKTX stock?

20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Nkarta, Inc.. The most recent filing was accepted on Jun 22, 2026.

Where does Trabud get NKTX insider trading data?

All NKTX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content